🔎 Trials Near Me

Utama › Skleroderma › Massachusetts

Kajian klinikal Skleroderma di Massachusetts

7 kajian untuk Skleroderma sedang mencari peserta di lokasi di Massachusetts.

Bandar di Massachusetts

Teks kajian rasmi (Bahasa Inggeris)

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  • Massachusetts General Hospital, Boston
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07497087

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  • Boston Medical Center, Boston
Mengambil pesertaFasa 1
Umur 18 hingga 70 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

  • Massachusetts General Hospital, Boston
  • Boston University (BU), Boston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06195072

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

  • Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT07090226

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Brigham And Womens Hospital, Boston
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT07115745

Open Label Treprostinil Raynaud's Study

  • Brigham and Women's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT07112183

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.